Clinical Study Evaluating The Role of Vonoprazan Versus Pantoprazole in Patients With Gastroesophageal Reflux Disease
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
This study aims to investigate the possible efficacy of vonoprazan versus Pantoprazole in patients with gastroesophageal reflux disease.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 17
Maximum Age: 60
Healthy Volunteers: f
View:
• Age 17-60 years.
• Both genders.
• Patients with a score ≥ 8 on the Gastroesophageal Reflux Disease Questionnaire (Gerd Q) are defined as having GERD and will enroll in this study and it will be done at baseline and after 8 weeks.
Locations
Other Locations
Egypt
Theodore Billiharz Institute for Researchs
RECRUITING
Giza
Contact Information
Primary
Aya Hany Abdel Aziz, Bachelor
PG_172956@pharm.tanta.edu.eg
+201144818823
Time Frame
Start Date: 2024-09-18
Estimated Completion Date: 2026-10
Participants
Target number of participants: 44
Treatments
Active_comparator: Vonoprazan 20mg (Vonseca)
• Group 1 (control group): 22 patients who will receive Vonoprazan 20mg (Vonseca) and placebo of pantoprazole (pantoloc) daily for 8 weeks
Active_comparator: Pantoprazole 40 mg (Pantoloc)
• Group 2: 22 patients who will receive Pantoprazole 40 mg (Pantoloc) and placebo of vonoprazan (vonseca) daily for 8 weeks.
Related Therapeutic Areas
Sponsors
Leads: Tanta University